We combine computational chemistry, math, and physics techniques to addresses the global need for new and improved medicines.
Our proprietary Molecule Creation Engine (MCE) dynamically produces tens of millions of diverse, virtual, drug-like molecules aimed at a particular disease target.
From this pool of candidates, our Molecule Modeling Engine (MME) identifies the most promising starting points for drug development using physics-based modeling.
We synthesize and test the most promising compounds in our state-of-the-art chemistry and biology labs and optimize them with the help of our computational engines.
This process allows us to develop multiple chemically distinct clinical candidates for each disease. We advance those drug candidates with the best preclinical profiles into clinical trials.